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INTRODUCTION 
 
Nucleotides, the structural subunits of the nucleic acids, are 
also important extracellular signaling molecules (Abbracchio and 
Burnstock, 1998; Burnstock, 2006). They are stored in cytosolic 
and secretory compartments of cells, and are released in response to 
cell injury, hypoxia, shear stress, and tissue injury (Bergfeld and 
Forrester, 1992; Grierson and Meldolesi, 1995; Sprague et al., 
1996). Nucleotides are also released in a regulated manner by 
platelets, endothelial cells, mast cells (MCs), macrophages, and T 
cells in response to physiologic activation (Milner et al., 1990; 
Osipchuk and Cahalan, 1992; Smith et al., 2010; Tokunaga et al., 
2010). Consequently, extracellular nucleotides accumulate at sites 
of vascular injury, hypoxia, thrombosis, inflammation, and immune 
cell activation. Both adenine-containing [adenosine triphosphate 
(ATP); adenosine diphosphate (ADP)] and uracil-containing 
[uridine triphosphate (UTP); uridine diphosphate (UDP)] 
nucleotides have cognate cell surface receptors that mediate their 
extracellular functions. These receptors fall into two classes; P2X 
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receptors, which are ligand-gated ion channels that mediate calcium 
and potassium fluxes in response to ATP, and P2Y receptors, which 
are G protein-coupled receptors (GPCRs) (Abbracchio et al., 2006; 
Burnstock and Knight, 2004; Khakh et al., 2001). Although adenine 
nucleotides and their receptors play established roles in platelet 
aggregation, pain perception, and cellular responses to hypoxic 
injury, the functions of many P2Y receptors in vivo remain 
unknown. 
P2Y6 receptors are the only known high affinity receptors 
selective for UDP. They are expressed on both hematopoietic 
(macrophages, dendritic cells, mast cells, T cells), and 
nonhematopoietic (vascular smooth muscle, epithelium, 
endothelium) cell types (Bar et al., 2008; Capra et al., 2005; Chang 
et al., 1995; Grbic et al., 2008; Jiang et al., 2009; Marcet et al., 
2007; Shin et al., 2008; Somers et al., 1998; Southey et al., 1996; 
Tsukimoto et al., 2009). Most functions attributed to P2Y6 
receptors in vitro suggest a role in modulating cellular responses to 
inflammation through autocrine or paracrine actions of uracil 
nucleotides. Endogenous uracil nucleotides amplify airway 
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epithelial chemokine production in response to neutrophil-derived 
peptides through P2Y6 receptors in vitro (Khine et al., 2006). P2Y6 
receptors are strongly expressed by colonic epithelial cells in 
biopsies from patients with inflammatory bowel disease, and 
mediate production of interleukin (IL)-8 by colonic epithelial cell 
lines in vitro (Grbic et al., 2008). P2Y6 receptors amplify 
chemokine generation by a lipopolysaccharide (LPS)-stimulated 
monocytic cell line (Warny et al., 2001), and enhance the release of 
macrophage inflammatory protein-1β by human MCs stimulated 
with leukotriene D4 (Jiang et al., 2009). Human T cells express 
P2Y6 receptors after activation in vitro and at sites of inflammation 
in vivo (Somers et al., 1998; Southey et al., 1996), and 
pharmacologic blockade of P2Y6 receptors inhibits proliferation, 
CD25 expression, and generation of cytokines by mouse T cells in 
response to polyclonal and antigen-specific stimulation (Tokunaga 
et al., 2010; Tsukimoto et al., 2009). Although these in vitro studies 
suggest physiologic functions for P2Y6 receptors in immune 
responses, such functions have yet to be demonstrated in vivo. 
Given its distribution on cells of both the innate and adaptive 
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immune systems, we suspected that P2Y6 receptors might play a 
role in the pathogenesis of allergic pulmonary inflammation. Here, 
we demonstrate that P2Y6 is an endogenous suppressor of T cell-
driven pulmonary pathology induced by exposure to the allergens 
of the house dust mite Dermatophagoides farinae, which are 
implicated as causative agents in asthma. Newly created C57BL/6 
mice bearing a conditional deletion of the P2Y6 receptor [p2ry6 
(flox/flox);cre/+ mice] displayed sharply increased pulmonary 
inflammation, lymph node hyperplasia, and allergeninduced Th1 
and Th2 recall responses compared with P2Y6-sufficient littermate 
controls [p2ry6 (flox/flox); (+/+) mice] when exposed intranasally 
to an extract (Df) of Dermatophagoides farinae. P2Y6 receptors 
were constitutively expressed at low levels by alveolar and lung 
interstitial macrophages, but absent on splenic and parabronchial 
lymph node (PLN) T cells from naïve mice. However, P2Y6 
receptor expression was induced on both CD4+ and CD8+ T cells 
from PLNs of +/+ mice exposed to Df. The absence of P2Y6 
receptors from CD4+ T cells of Df-challenged mice, but not from 
lung-derived macrophages used as antigen presenting cells (APCs), 
 7
was sufficient to increase Th1 and Th2 cytokine generation in an 
antigen restimulation assay. Thus, the inducible expression of P2Y6 
receptors by T cells permits endogenous UDP to modify cellular 
activation and cytokine production, thus dampening the lung 
inflammatory response to the clinically relevant allergens of house 
dust mites. 
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MATHERIALS  AND  METHODS 
 
Generation of +/+ and p2ry6 (flox/flox);cre/+ mice 
To generate a viable mouse with a disrupted p2ry6 gene, we 
chose a conditional knockout strategy using the established 
Cre/loxP system. To construct the conditional genetargeting vector, 
a 12.7 kb region was subcloned from a B6 bacterial artificial 
chromosome (BAC) clone using homologous recombination 
(Figure 1A). A single loxP site was inserted at the 5′ side of exon 3 
and a PGK-Neo cassette flanked by FRT sites and loxP sites was 
inserted at the 3′ of exon 3. The region of the targeting vector was 
designed such that the long (LA) and the short (SA) homology arms 
extended 9.6 kb at the 5′ side and 2.1 kb at the 3′ of the cassette, 
respectively. Thus, the target region was ~1.8 kb and included exon 
3. The structure of the targeting vector was confirmed by restriction 
analysis after each modification step and by sequencing using 
primers designed to read from the selection cassette into the 3′ of 
the LA (N7) and the 5′ end of the SA (N1) and primers annealing to 
the vector sequence (P6 and T7) and reading into the 5′ and 3′ ends 
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of the BAC subclone (Figure 1A). The BAC was subcloned into a 
2.4 kb subclone vector containing an ampicillin cassette for 
retrotransformation of the construct prior to electroporation. The 
resultant targeting vector was linearized and electroporated into 
129/Sv mouse embryonic stem (ES) cells and cells were positively 
selected with G418. Six verified ES clones were microinjected into 
blastocysts from C57BL/6 mice and chimeric mice were obtained 
and crossed with C57BL/6 mice to produce male and female p2ry6 
(flox/+) mice. To generate p2ry6 (flox/flox) and p2ry6 
(flox/flox);cre/+ mice on a C57BL/6 x 129 mixed background, 
p2ry6 (flox/+) mice were intracrossed to produce p2ry6 (flox/flox) 
mice. P2ry6 (flox/flox) mice were then mated with C57BL/6 mice 
homozygous for the Cre recombinase (cre/cre, C57BL/6 
rosa26CreER(T2); TaconicArtemis GmbH, Cologne, Germany) to 
obtain p2ry6 (flox/+);cre/+ mice that were then mated with p2ry6 
(flox/flox) mice to produce the experimental mice, p2ry6 (flox/flox) 
(+/+ mice) and p2ry6 (flox/flox);cre/+ (Figure 1B). Once p2ry6 
(flox/flox) and p2ry6 (flox/flox);cre/+ were obtained, they were 
also used as breeders for the maintenance of the colony. In order to 
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generate mice of complete C57BL/6 genetic background, p2ry6 
(flox/+) mice were backcrossed with WT C57BL/6 mice up to the 
tenth generation (N10). N10 p2ry6 (flox/+) mice were then mated 
with cre/cre mice according to the same format described above to 
finally obtain p2ry6 (flox/flox) and p2ry6 (flox/flox);cre/+ mice. In 
order to induce the Cre recombinase in 5-11 week-old p2ry6 
(flox/flox);cre/+ mice, tamoxifen (1 mg; Sigma), dissolved in a 
mixture of ethanol/sunflower seed oil (1:4.5, v/v), was injected 
intraperitoneally daily over 5 consecutive days (Feil et al., 2009). 
Cohorts of sex- and age-matched p2ry6 (flox/flox) mice were also 
administered tamoxifen simultaneously to ensure an equal treatment 
of the two strains. Tamoxifen-mediated induction of Cre 
recombinase in p2ry6 (flox/flox);cre/+ mice resulted in the 
disruption of p2ry6 gene (Figures 4 and 8C). Equally treated p2ry6 
(flox/flox) did not show any genetic modification of p2ry6 gene 
(Figures 4 and 8C). The mice of the two genotypes were of 
comparable weight both before the administration of tamoxifen and 
at beginning of the treatment with Df (males: +/+ mice, 25.1 ± 0.3 
and 26.7 ± 0.4 g, n = 18; p2ry6 (flox/flox);cre/+ mice, 25.4 ± 0.3 
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and 26.1 ± 0.3 g, n = 17; females: +/+, 20.2 ± 0.3 and 21.6 ± 0.2 g, 
n = 13; p2ry6 (flox/flox);cre/+, 19.8 ± 0.4 and 21.1 ± 0.6 g, n = 12; 
from two independent experiments), were indistinguishable 
clinically and at the histological analysis of lungs, trachea, bone 
marrow, spleen, liver, stomach, jejunum, colon, kidney, and heart 
and had similar complete peripheral blood and leukocyte 
differential count (data not shown). 
Mice were genotyped before and after the administration of 
tamoxifen by semiquantitative PCR of genomic DNA isolated from 
proteinase K- (from Tritirachium album, Sigma) digested tail 
samples. Primer sequences were: wild-type p2ry6, forward 5'-
AGCCTGGTCTACACAGTGAAA-3', reverse 5'-
GTAGGGATTCAACATTAGGAG-3'; floxed p2ry6, forward 5'-
CTTCCTGACTAGGGGAGGAG-3', reverse 5'-
GTAGGGATTCAACATTAGGAG-3'; Cre recombinase, forward 
5'-CCATCATCGAAGCTTCACTGAAG-3', reverse 5'-
GGAGTTTCAATACCCGAGATCATGC-3'. 
Mice were housed under specific pathogen-free conditions and 
maintained on a 12-hour light/dark cycle for the entire duration of 
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the studies. All the studies described were approved by the Animal 
Care and Use Committee of the Dana Farber Cancer Institute 
(Boston, MA). 
 
Df-induced pulmonary inflammation 
Ten days after the administration of tamoxifen, pulmonary 
inflammation was induced in age- (7-13 weeks) and sex-matched 
+/+ and p2ry6 (flox/flox);cre/+ mice by intranasal instillation of 3 
μg of the Dermatophagoides farinae house dust mite extract (Df; 
Greer Laboratories, Lenoir, NC) in 20 μl of NaCl 0.9 % (containing 
<0.005 EU/ml of endotoxin; Sigma, St. Louis, MO) twice a week 
for 3 weeks, as described in (Giannattasio et al., 2010; Lundequist 
et al., 2010). In selected experiments the amount of Df was lowered 
to 1 μg/dose. Control groups of +/+ and p2ry6 (flox/flox);cre/+ 
mice received NaCl 0.9% alone. The same protocol was used for 
the experiments with the cre/+ mice. Twenty-four h after the last 
treatment, mice were euthanized and blood was collected by cardiac 
puncture and centrifuged to obtain serum. Mice were then 
cannulated and bronchoalveolar lavage (BAL) was performed with 
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three aliquots of 0.7 ml of icecold PBS containing 10% FBS and 0.5 
mM EDTA. BAL fluid cells were cytocentrifuged onto slides, 
stained with Diff-quick (Fisher Diagnostic, Middletown, VA), and 
differentially counted as mononuclear cells (MNCs, 
monocytes/macrophages and lymphocytes), neutrophils, or 
eosinophils, according to the standard hemocytological criteria 
(Giannattasio et al., 2010). 
 
Histological evaluation of pulmonary inflammation 
Left lungs were collected from the mice at the time of 
euthanasia, fixed for at least 8 h in 4% paraformaldehyde, washed 
twice with PBS containing 2% DMSO, suspended in 50 mM NH4Cl 
overnight at 4°C and finally embedded in paraffin or 
glycolmethacrylate (Friend et al., 2000). Two-micrometer-thick 
sections were stained with hematoxylin-azue-2 eosin (H&E) to 
assess inflammatory cell infiltrates. For histological study of the 
mucus-secreting cells of the airway epithelia (goblet cells), lung 
sections were stained with Periodic acid-Schiff (PAS). The extent 
of cellular infiltration of the tissue was evaluated on fifteen 
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bronchovascular bundles (BVBs) of comparable large-caliber 
preterminal bronchi (diameter 200-200 μM) by a pathologist 
without knowledge of the particular mouse genotype or procedure. 
The goblet cells positively stained for the presence of mucus at the 
PAS reaction were enumerated in at least four independent BVBs of 
each lung and data were expressed as the average of goblet cell 
counts stained in the bronchi of each section per millimeter of 
bronchial basal lamina, as measured by Image J (National Institutes 
of Health image analysis software [http://rsbweb.nih.gov/ij]) 
(Giannattasio et al., 2010). 
 
Real-time quantitative PCR (qPCR) of mRNA transcripts in the 
lung and PLNs 
Right lungs were collected at time of euthanasia and snap 
frozen. Freshly isolated PLN cells were pooled from 5-7 
mice/group. Total RNA was isolated from tissue homogenates and 
from PLN cells with Tri-Reagent (Sigma), reverse transcribed into 
cDNA (RT2 First Strand kit, SABiosciences, Frederick, MD), and 
assayed by real-time qPCR for mouse P2Y6, IL-5, IL-13, the 
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mucus-associated proteins Muc5ac and Clca3/Gob-5, the 
transcription factors T-bet, GATA-3, and ROR-γT, and GAPDH on 
a Mx3005P thermal cycler (Stratagene) with the use of 
SYBR®Green/ROX® master mix (SABiosciences). The ratio of 
each mRNA relative to the GAPDH mRNA was calculated with the 
ΔΔCt method. The primers used for mouse P2Y6 (Bar et al., 2008), 
IL-5, IL-13, Muc5ac, Clca3/Gob-5 and GAPDH were previously 
reported (Giannattasio et al., 2010). For the transcription factors, 
the fold-induction was calculated based on the ratio of corrected 
expression in the samples from Df-treated mice and from saline-
treated controls. 
 
Immunohistochemical analysis of P2Y6 in lungs, PLNs and spleen 
For immunohistochemical analysis of P2Y6 receptors, sections 
of paraffin-embedded lungs, PLNs and spleens were deparaffinized 
and rehydrated. Antigen retrieval was performed with Target 
Retrieval Solution (Dako, Denmark) at 97°C for 30 min. After 
blocking with 10% chicken serum (Santa Cruz Biotechnologies, 
Santa Cruz, CA), sections were incubated (1 h, 37ºC) with 43 μg/ml 
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of a rabbit anti-P2Y6 Ab (Jiang et al., 2009) and then with the 
peroxidaseconjugated rabbit ABC staining system (Santa Cruz) 
according to the manufacturer’s instructions. Slides were analyzed 
with a Leica DM LB2 microscope (Leica Microsystems, Wetzlar, 
Germany) and pictures captured with a Nikon digital camera DXM 
1200 with Nikon ACT-1 (version 2.70) image acquisition software. 
 
Flow cytometry analysis of P2Y6 receptors on PLN cells 
Pooled PLNs from NaCl- and Df-treated +/+ and p2ry6 
(flox/flox);cre/+ mice were homogenized and red cells were lysed. 
The cells obtained were fixed, permeabilized by incubation in 
FACS buffer [PBS buffer containing 0.5% bovine serum albumin 
(Sigma)] + 0.1% saponin (from Quillaja saponaria, Sigma) and 
blocked in FACS buffer containing 10% normal mouse serum and 
1% anti-mouse CD16/CD32 (Mouse BD Fc BlockTM, BD 
Biosciences, San Jose, CA). Cells were washed and incubated (45 
min, 4ºC) with the following Abs: allophycocyanin-CD4 (clone 
RM4-5), allophycocyanin-CD8b (H35-17.2), PE-Cy7-CD11c 
(N418), PerCP-Cy5.5-B220 (RA3-6B2) (eBioscience), and Alexa 
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Fluor 488-labeled (Zenon Alexa Fluor 488 rabbit IgG labeling kit, 
Invitrogen) rabbit anti-P2Y6 [10 μg/ml; (Jiang et al., 2009)]. The 
corresponding isotypes (eBioscience) or Alexa Fluor 488-labeled 
normal rabbit IgG (Jackson ImmunoResearch Laboratories) were 
used as controls. The acquisition was performed on a FACSCanto 
flow cytometer with FACSDiva software (BD Biosciences), and 
data were analyzed with FlowJo (Tree Star, Ashland, OR). 
 
In vitro restimulation of lymph node cells with Df 
The PLN was collected from the upper-right chest of each 
mouse and homogenized in complete medium [RPMI, 10% FBS, 
1% non-essential amino acids, 2 mM L-glutamine, 100 U/ml 
penicillin, 100 μg/ml streptomycin, 50 μM 2-ME (Sigma)], plus 25 
mM HEPES, and 1 mM sodium pyruvate. The red cells were lysed, 
and 4 x 106 nucleated cells were incubated for 72 h with medium 
alone or containing 20 μg/ml Df (Giannattasio et al., 2010). The 
concentrations of IL-2, IL-4, IL-5, IL-10, IL-13, IL-17A, and IFN-γ 
released in the supernatants were measured by ELISA (eBioscience, 
San Diego, CA). The amount of cytokine per 106 PLN cells and the 
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total number of PLN cells were used to calculate the total amount of 
cytokine generated per lymph node. 
For the ELISPOT analysis, 2.5 x 105 PLN nucleated cells were 
incubated in medium containing Df 20 μg/ml for 72 h on 96-well 
cell culture plates with PVDF filter membranes (Millipore, 
Billerica, MA), precoated with Abs against IL-4, IL-5, IL-13, IL-
17A, and IFN-γ (eBioscience). At the end of the incubation, the 
cells were removed, the wells washed and spots were detected with 
an ELISPOT kit (eBioscience) according to the manufacturer’s 
instructions and counted with a CTL Immunospot® Analyzer 
(Cellular Technology, Shaker Heights, OH). For each cytokine the 
total number of producing cells was calculated by multiplying the 
frequency of producing cells by the total number of PLN cells. 
 
Measurement of total and Df-specific serum Igs 
Serum from NaCl- and Df-treated +/+ and p2ry6 
(flox/flox);cre/+ mice was assayed by ELISA for total IgE content 
by a commercially available kit (BD Biosciences). Df-specific IgG1 
was measured by ELISA with plate-bound Df, an alkaline 
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phosphatase-conjugated anti-mouse IgG1 (Southern Biotech, 
Birmingham, AL) and substrate solution (p-nitrophenyl phosphate, 
Sigma). Absorbance was read at 405 nm, and the results were 
expressed as net O.D., as described in (Giannattasio et al., 2010). 
 
PLN CD4+ T cell proliferation 
PLN cells from NaCl- or Df-treated +/+ and p2ry6 
(flox/flox);cre/+ mice were obtained, incubated (10 min, 37ºC) in 
PBS with 1 μM CFDA-SE (eBioscience) and extensively washed in 
culture medium. 4 x 106 CFDA-SE-labeled cells were then added to 
24-well plates precoated with an anti-CD3 Ab (1 μg/ml overnight) 
and cultured in the presence of soluble anti-CD28 Ab (1 μg/ml) for 
72 h. At the end of the incubation cells were harvested, washed in 
FACS buffer, blocked and incubated (45 min, 4ºC) with APC-CD4 
Ab (RM4-5, eBioscience). The acquisition and the analysis were 
performed as described. 
 20
 Isolation of lung interstitial macrophages and confocal microscopy 
Interstitial macrophages were obtained using a modification of 
previous protocols (Triggiani et al., 1994; Vermaelen and Pauwels, 
2004). After removing airway cells and alveolar macrophages by 
extensive BAL with PBS containing EDTA, lungs were 
homogenized through a 70 μm mesh in ice cold complete medium, 
washed and incubated (30 min, 37ºC) with 428 U/ml Collagenase 
IV (from Clostridium histolyticum; Worthington, Lakewood, NJ) 
and 20 μg/ml DNAse I (from bovine pancreas; Roche, Mannheim, 
Germany). The obtained cell suspension was washed and layered 
onto a Percoll® gradient (60% and 40%). After centrifugation the 
cells at each interface were collected, washed, and centrifuged 
again on a second density gradient. At the end of the procedure the 
obtained cells, representing an enriched (>85%) population of 
interstitial macrophages, were stained with Diff-quick (Fisher 
Diagnostic) or analyzed by flow cytometry with the following 
antibodies: allophycocianin-CD68 (clone FA-11; AbD Serotec), 
FITC-MHC-II (M5/114.15.2), PE-Cy7-CD11c, (N418), PE-Cy7-
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CD3e (145-2C11), FITC-CD4 (RM4-5), PE-Cy7-CD8a (53-6.7), 
and PerCP-Cy5.5-B220 (RA3-6B2) (eBioscience). 
For confocal microscopy analysis, the macrophages were 
further enriched by adherence (overnight, 37ºC) on cover slips. 
After removing non-adherent cells by washing, adherent 
macrophages were fixed with 2% paraformaldehyde (Sigma) and 
permeabilized with PBS containing 0.1% saponin (Balestrieri et al., 
2009). Cells were incubated (1 h, RT) with goat polyclonal anti- 
P2Y6 antibody or goat IgG as negative control (10 μg/ml; Santa 
Cruz). Cells were then incubated (1 h, RT) with FITC-conjugated 
donkey anti-rabbit IgG (Jackson ImmunoResearch) and pictures 
were acquired by using a Nikon C1 plus laser scanner confocal 
system combined with an Eclipse TE2000-U inverted microscope 
with a x60 oil PlanApo NA 1.4 objective lens. Eight to 10 Z-stack 
images were acquired and each image (0.5 μm) was saved as a 
series of independent sections (Balestrieri et al., 2009). 
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Cocultures of lung macrophages and splenic CD4+ T cells 
Interstitial macrophages were obtained as described. To purify 
CD4+ T cells, spleens of NaCl- or Df-treated +/+ and p2ry6 
(flox/flox);cre/+ mice were homogenized and nucleated cells were 
blocked and incubated (45 min, 4ºC) with PE-Cy7-CD3e (clone 
145-2C11) and FITC-CD4 (RM4-5) Abs (eBioscience). The double 
positive CD3+/CD4+ cells were sorted by flow cytometry (Dana 
Farber Cancer Institute Flow Cytometry Facility, Boston, MA). 
Lung interstitial macrophages (1 x 105/ml) and CD3+/CD4+ cells 
(7.5 x 105/ml) were cocultured in either medium alone or containing 
20 μg/ml Df for 72 h. At the end of the incubation the 
concentrations of IL-5, IL-13, and IFN-γ released in the 
supernatants were measured by ELISA (eBioscience). 
 
Statistics 
Non-parametric Mann-Whitney test and Kruskal-Wallis test 
with Dunn`s post test correction for multiple comparisons were 
used to compare two and three or more groups, respectively. 
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Analysis was performed with Prism software (GraphPad, La Jolla, 
CA). Values of p < 0.05 were considered significant. 
 24
RESULTS 
 
Deletion of P2Y6 receptors increases the pulmonary 
inflammation induced in vivo by exposure to Df allergen 
The p2ry6 allele was conditionally deleted by flanking the 
gene with P-lox sites (Figure 1A). The p2ry6 (flox/flox);cre/+ mice 
and their +/+ littermate controls were created using the breeding 
scheme outlined in Figure 1B. The deletion of the p2ry6 allele was 
accomplished by the administration of tamoxifen for 5 consecutive 
days intraperitoneally. PCR analysis was used to confirm the 
genotype of the mice used in the experiments (Figure 1C). 
Immunohistochemistry confirmed the absence of the P2Y6 receptor 
protein in the lungs, PLN and spleen of the p2ry6 (flox/flox);cre/+ 
mice after tamoxifen treatment (Figure 4 and data not shown). The 
initial experiments were performed with F1-F5 C57BL/6 x 129 
mice and littermate controls. The results obtained in these 
experiments were similar to those obtained after backcrossing the 
mice for 10 generations to the C57BL/6 background (Figures 2A 
and 2B). 
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To determine whether P2Y6 receptors played a role in the 
development of allergic pulmonary inflammation, Df (3 μg of 
protein in 20 μl of NaCl 0.9 %) or saline control was administered 
intranasally, twice weekly for three consecutive weeks (Lundequist 
et al., 2010) to cohorts of +/+ and p2ry6 (flox/flox);cre/+ mice after 
both genotypes were treated with tamoxifen. Twenty-four hours 
after the last instillation, mice were euthanized and exsanguinated, 
BAL was performed and the organs were harvested. Compared with 
the saline-treated controls, both strains showed significant increases 
in total BAL fluid cell numbers, eosinophils, neutrophils, 
macrophages, and lymphocytes when treated with Df. However, the 
total number of cells in BAL fluid of the Df-treated p2ry6 
(flox/flox);cre/+ mice exceed that of the +/+ controls by more than 
2-fold (Figure 2A). Compared to the Df-treated +/+ controls, the 
Df-treated p2ry6 (flox/flox);cre/+ mice showed ~5-fold higher 
numbers of BAL fluid eosinophils and neutrophils (Figure 2A). 
Similar results were obtained after backcrossing the initial F1 mice 
to the C57BL/6 background for 10 generations (Figure 2B). 
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To ensure that the activation of the Cre recombinase used to 
generate the conditional knock-out mouse did not alter the 
inflammatory response induced by the Df in the lung, we treated 
C57BL/6 cre/+ mice and WT controls with tamoxifen to activate 
the Cre recombinase and exposed them to NaCl or Df (3 μg) The 
strains showed essentially identical degrees of Df-induced 
inflammation (Figure 3). 
 
To determine the effect of P2Y6 receptor deficiency on of the 
development of lung pathology induced by Df, we stained the lungs 
with hematoxylin-azure-2 eosin to identify cellular infiltrates, and 
by the periodic acid-Schiff reaction to detect goblet cell metaplasia. 
Because the inflammation caused by Df at 3 μg was too severe to 
show substantial differences between the genotypes (data not 
shown), we reduced the dose of Df to 1 μg in selected experiments 
to determine whether the deletion of P2Y6 receptors produced an 
increment in pulmonary inflammation at a lower dose of antigen. At 
this allergen dose, the bronchovascular bundles (BVBs) of the 
p2ry6 (flox/flox);cre/+ mice contained more extensive 
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inflammatory infiltrates consisting of mononuclear cells along with 
eosinophils, neutrophils, lymphocytes and plasma cells than did the 
+/+ controls (Figure 2C). In addition, the bronchial epithelium of 
the p2ry6 (flox/flox);cre/+ mice demonstrated more extensive 
hyperplasia of mucus-producing goblet cells than did the +/+ 
controls (Figure 2C). Quantitative PCR of the lung RNA revealed 
higher levels of expression of IL-5 and IL-13 transcripts in the 
lungs of the Df-treated p2ry6 (flox/flox);cre/+ mice than in the 
lungs of the +/+ mice, with similar trends for the goblet cell-
associated transcripts Muc5ac and Clca3/Gob-5 (Figure 2D). 
 
Cellular distribution of P2Y6 receptors in the lungs and 
lymphoid tissues 
Because the deletion of P2Y6 receptors resulted in increased 
pulmonary inflammation in response to Df, we sought to determine 
the cellular distribution of P2Y6 receptors in the lungs and 
associated secondary lymphoid organs of +/+ mice, and whether 
this distribution and the level of receptor expression changed with 
the induction of inflammation. qPCR revealed low constitutive 
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levels of P2Y6 receptor mRNA in the lungs of naïve +/+ mice. 
These levels sharply increased in response to intranasal Df (Figure 
4A). Immunohistochemistry of the lungs of saline and Df-treated 
+/+ mice using a rabbit polyclonal anti-P2Y6 antibody (Jiang et al., 
2009) revealed that P2Y6 receptor protein localized predominantly 
to cells with the morphologic appearance of macrophages in the 
alveolar and interstitial spaces (Figure 4B). Challenge of +/+ mice 
with Df induced the accumulation of mononuclear cells in the 
bronchus-associated lymphoid tissue of the BVBs, which stained 
strongly for P2Y6 receptor protein. Based on cell size and 
morphology, these cells appeared to be a mixture of lymphocytes 
and monocyte-like cells (Figure 4B). There was negligible staining 
of the resident epithelial, endothelial, and smooth muscle cells, and 
no significant staining of the infiltrating granulocytes. 
Immunostaining of the spleen and PLNs from naïve +/+ mice 
revealed negligible staining for P2Y6 receptor protein. In contrast, 
distinct populations of P2Y6 receptor-positive cells appeared in the 
paracortical zones of the spleen and PLNs from Df-treated +/+ mice 
(Figure 4C), but not in the germinal centers. Neither the lung 
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(Figure 4B) nor the lymphoid tissues (Figure 4C) of the saline- or 
Df-treated p2ry6 (flox/flox);cre/+ mice exhibited staining for P2Y6 
receptor protein. 
To identify the lymphoid cells inducibly expressing P2Y6 
receptors after treatment with Df, we performed flow cytometry 
using the rabbit anti-P2Y6 antibody on the dispersed spleen cells 
from the +/+ mice. Antibodies against CD4, CD8, B220 (CD45R), 
and CD11c were used to identify helper and cytotoxic T cells, B 
cells and APCs, respectively (Figure 5A). No P2Y6-expressing 
lymphoid cells were identified in the spleens from the naïve +/+ 
mice (Figure 5B). In contrast, both CD4+ and (to a lesser extent) 
CD8+ splenic T cells from the Df-treated +/+ mice showed modest 
staining for P2Y6 (Figure 5B). B220+ B cells did not express P2Y6 
receptors, whether derived from naïve or Df-treated +/+ mice. There 
were too few CD11c+ cells to analyze, and no staining for P2Y6 
receptors was observed on any cell populations in the spleens from 
saline- or Df-treated p2ry6 (flox/flox);cre/+ mice (Figure 5B). The 
percentages of CD4+, CD8+, and B220+ cells in the lymph nodes 
did not differ between the two strains (not shown). 
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 Effects of P2Y6 receptors on the adaptive immune response to 
Df 
To determine the role of P2Y6 receptors on control of recall 
responses to the Df antigens in sensitized mice, we evaluated the 
production of proinflammatory and immunoregulatory cytokines 
from restimulated PLN cells from the Df-treated p2ry6 
(flox/flox);cre/+ mice and +/+ controls. The PLNs from the Df-
treated p2ry6 (flox/flox);cre/+ mice were consistently larger than 
those from the +/+ controls, and contained more total cells (Figure 
6A). Equal numbers of PLN cells isolated from NaCl- and Df-
treated +/+ and p2ry6 (flox/flox);cre/+ mice were cultured in vitro 
in either medium alone or containing Df. At the end of the culture, 
the concentrations of IL-2, IL-4, IL-5, IL-10, IL-13, IL-17A, and 
IFN-γ released in the supernatants were evaluated by ELISA. There 
was no significant cytokine generation by unstimulated cells from 
either genotype, or by Df-stimulated cells from naïve mice (data not 
shown). Restimulated PLN cells from Df-treated p2ry6 
(flox/flox);cre/+ mice generated higher levels of IL-4, IL-5, IL-13, 
 31
and IFN-γ than did cells from +/+ mice (Figure 6B). The amounts 
of IL-2, IL-10 and IL-17A also tended to be higher but did not 
reach significance. To determine whether the increased quantities of 
cytokines reflected increased numbers of cytokine-generating cells 
in the PLNs from Df-treated p2ry6 (flox/flox);cre/+ mice, we 
performed ELISPOT assays. Consistent with the ELISA data, the 
PLNs of Df-treated p2ry6 (flox/flox);cre/+ mice contained 
increased numbers of cells expressing IL-4, IL-5, and IL-13 protein 
than did the PLNs of the Df-treated +/+ controls (Figure 6C). The 
differences in IFN-γ and IL-17A were not significant. 
Quantitative PCR analysis showed that the freshly isolated 
PLN cells obtained from Df-treated p2ry6 (flox/flox);cre/+ mice 
exhibited stronger induction (over the PLN cells from 
corresponding saline-treated controls) of the Th1-associated 
transcription factor T-bet than did PLN cells from +/+ control mice 
[7.9-fold induction vs. 2.6-fold induction in PLN cells from Df-
treated p2ry6 (flox/flox);cre/+ and +/+ mice, respectively; data from 
5-7 pooled samples/group]. Similar results were obtained for the 
Th2-associated transcription factor GATA-3 [5.4-fold induction vs. 
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3.5-fold induction for p2ry6 (flox/flox);cre/+ and +/+ PLN cells, 
respectively]. In contrast, the PLN cells from the two strains 
showed equivalent induction of the regulatory T cell (Treg) 
associated transcription factor FoxP3 [4.4 vs. 4.0-fold induction for 
p2ry6 (flox/flox);cre/+ and +/+ PLN cells, respectively]. PLN cells 
from p2ry6 (flox/flox);cre/+ mice showed weaker induction of the 
Th17 transcription factor ROR-γT (0.4 vs. 1.1-fold) than did the 
PLN cells from the +/+ controls (data not shown). 
To determine whether the absence of P2Y6 receptors changed 
the rate of helper T cell proliferation, PLN cells were loaded with 
CFDA-SE before restimulation and the dilution of the dye was 
measured cytofluorographically as an index of proliferation. Since 
the CFDA-SE dilution signal in cultures of PLN cells restimulated 
with Df was below the limit of detection (data not shown), we 
performed the assay by using a T cell polyclonal stimulation with 
anti-CD3 and anti-CD28 antibodies. Percentages of proliferating 
CD4+ T cells were consistently ~10% higher in the PLNs of p2ry6 
(flox/flox);cre/+ mice than in the PLNs of +/+ controls, regardless 
of whether the samples came from saline-treated or Df-treated mice 
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(54.91 ± 6.52 vs. 44.10 ± 4.76 % proliferating CD4+ cells in PLNs 
of Df-treated p2ry6 (flox/flox);cre/+ vs. +/+ controls, respectively, n 
= 10 mice/group, as shown for one representative mouse per group 
from one of two experiments, Figure 6D). The 
p2ry6 (flox/flox);cre/+ mice exposed to Df showed higher levels of 
serum total IgE (Figure 7A), but they had comparable levels of Df-
IgG1 (Figure 7B). 
 
The absence of P2Y6 receptors on CD4+ T cells controls the 
recall response to Df-associated allergens 
To determine whether the increased production of cytokines 
from the restimulated PLNs reflected a direct suppressive effect of 
P2Y6 receptors expressed by T cells, or an indirect effect of P2Y6 
receptor-dependent modulation of APC functions, we developed a 
co-culture assay. Because there are no available transgenic mice 
with dust mite allergen-specific T cell receptors, we purified 
CD3+/CD4+ T cells from the spleens of NaCl- and Df-treated +/+ 
and p2ry6 (flox/flox);cre/+ mice and incubated them with enriched 
interstitial macrophages from the lungs of each genotype and 
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treatment as a source of APCs. After enrichment, nearly all of these 
cells had morphologic features of macrophages (Figure 8A), with 
>85% expressing the pan-macrophage marker CD68 (Figure 8B) 
(Rabinowitz and Gordon, 1991). Less than 5% of the cells 
expressed T cell markers (CD3, CD4 and CD8); while B220 was 
expressed by ~15% of the CD68+ cells (data not shown). The 
proportions of the cells expressing the APC markers CD11c and 
MHC-II (~40% for each marker) did not differ between genotypes, 
and confocal imaging confirmed that the macrophages from the Df-
treated +/+ mice exhibited substantially increased expression of 
P2Y6 protein relative to the saline-treated controls (Figure 8C). 
Macrophages from both naïve and Df-treated mice were co-cultured 
with the sorted CD4+ T cells at a fixed ratio in the presence of Df 
for 72 h. CD3+/CD4+ T cells from naïve mice of both genotypes 
generated small and comparable amounts of IL-5, IL-13 (Figure 9, 
left panels). In contrast, CD3+/CD4+ T cells from Df-treated p2ry6 
(flox/flox);cre/+ mice released more IL-5, IL-13, and IFN-γ than 
the cells from +/+mice (Figure 9, right panels). There was no effect 
of the macrophage genotype, although macrophages from lungs of 
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Df-treated mice supported higher levels of cytokine generation by 
CD4+ cells than did macrophages from the lungs of saline-treated 
controls (Figure 9). 
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DISCUSSION 
 
This study uncovers a prominent role for the UDP-selective 
P2Y6 receptor in the control of pulmonary inflammation and 
cytokine generation in a model of allergic pulmonary inflammation. 
In contrast to the inductive effects of adenine nucleotides (Idzko et 
al., 2007), which facilitate the development of allergen-induced 
pulmonary inflammation by breaking tolerance through effects on 
dendritic cell-associated P2Y receptors, the uracil nucleotides 
released during this model of pulmonary inflammation act at P2Y6 
receptors that are inducibly expressed by T cells to suppress the 
development of Df antigen-responsive T cells and production of 
pathogenetic cytokines. In this context, the upregulation of P2Y6 
receptors on T cells may be a mechanism that limits the pathologic 
consequences of a pulmonary immune response to allergens that 
commonly sensitize humans during the development of asthma. 
In addition to expression by vascular smooth muscle (Chang et 
al., 1995), and epithelial cells of the respiratory tract and intestine 
(Grbic et al., 2008; Marcet et al., 2007), P2Y6 receptors are 
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expressed by macrophages (Bar et al., 2008; Capra et al., 2005), 
dendritic cells (Idzko et al., 2004; Shin et al., 2008), T cells 
(Communi et al., 1996; Somers et al., 1998; Southey et al., 1996; 
Tokunaga et al., 2010; Tsukimoto et al., 2009), and MCs (Jiang et 
al., 2009). Although previous studies suggested that P2Y6 receptors 
primarily serve to amplify cytokine generation by these cells in 
response to stimuli such as LPS or neutrophil-derived antimicrobial 
peptides (Khine et al., 2006; Warny et al., 2001), P2Y6 receptor 
signaling can also suppress certain cellular functions in vitro 
(CysLT1R signaling, cytokine generation by dendritic cells 
activated through TLRs) (Capra et al., 2005; Shin et al., 2008) 
through protein kinase C-dependent mechanisms. There are no 
previous studies of the role for P2Y6 receptors in an integrated 
immune response in vivo. 
We generated a mouse with homozygous floxed p2ry6 alleles 
[p2ry6 (flox/flox)] (Figure 1A) that were disrupted by tamoxifen 
treatment after introducing a single copy of a tamoxifen-sensitive 
Cre recombinase allele [p2ry6 (flox/flox);cre/+] (Figures 1B and 
1C). These mice were fertile, healthy, and indistinguishable from 
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littermate +/+ controls, similar to a previously reported conditional 
p2ry6-/- mice reported in (Bar et al., 2008). We used these mice and 
their littermates to determine the role of P2Y6 receptors in a model 
of pulmonary inflammation induced by Df, an extract that contains 
glycans, proteases, and other stimuli that activate lung APCs and 
initiate a pathogenetic T cell response with the generation of Th1, 
Th2, and Th17 cytokines and the development of characteristic 
pulmonary inflammation (Barrett et al., 2009; Giannattasio et al., 
2010; Maekawa et al., 2010) when administered intranasally. This 
model can therefore be used to determine potential contributions 
from P2Y6 receptors on both the innate and adaptive immune 
systems to the development of pulmonary pathology. Based on the 
role for P2Y6 receptors in amplifying cytokine production by 
immune cells in vitro, we anticipated that the deletion of this 
receptor might reduce inflammation in our model. We were 
surprised to find that the p2ry6 (flox/flox);cre/+ mice exhibited 
increased inflammation after Df administration compared with the 
+/+ littermates, showing significantly increased total cell counts, 
increased eosinophil and neutrophil counts in the BAL fluid 
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(Figures 2A and 2B), as well as increased bronchovascular cellular 
infiltration and goblet cell metaplasia on histological analysis 
(Figure 2C). The increases in goblet cell-associated transcripts in 
the lungs of p2ry6 (flox/flox);cre/+ mice, which are 
characteristically controlled by the Th2 cytokine IL-13 (Kuperman 
et al., 2002; Nakanishi et al., 2001; Wills-Karp et al., 1998; Zuhdi 
Alimam et al., 2000), was paralleled by increased quantities of 
transcripts encoding IL-13, as well as IL-5, the major cytokine 
responsible for eosinophilia (Foster et al., 1996; Hogan et al., 1997) 
(Figure 2D). These data suggested that the absence of P2Y6 
receptors increased the expression of pathogenetic Th2 cytokines in 
the target tissue, leading to characteristic lung pathology. 
While cytokine generation in models of allergen-induced 
pulmonary disease requires T cell activation following the 
presentation of antigens by APCs (Barrett and Austen, 2009; Barrett 
et al., 2009; Giannattasio et al., 2010; Trompette et al., 2009), 
several additional cell types, including epithelial cells, modify 
cytokine generation by recognizing non-protein components of dust 
mites (Barrett et al., 2009; Hammad et al., 2009; Trompette et al., 
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2009). We therefore sought to determine the distribution and the 
levels of P2Y6 receptor expression in resident lung cells in both 
naïve and Df-treated mice. Although airway epithelial cells are 
reported to express P2Y6 receptors, the dominant P2Y6 expressing 
cells in the lungs of naïve +/+ mice were macrophages in both the 
alveolar and interstitial spaces of the lung (Figure 4B). The sharply 
increased expression of P2Y6 receptor transcript in the lungs of Df-
treated +/+ mice (Figure 4A) was paralleled by the appearance of 
monocytoid and lymphocytoid cells that strongly expressed P2Y6 
receptor protein, and that localized to the bronchus-associated 
lymphoid tissues (Figure 4B). Additionally, staining of the regional 
lymph nodes and of the spleen suggested that Df treatment of +/+ 
mice induced a P2Y6 receptor-expressing T cell population (Figure 
4C), and flow cytometry verified that PLN CD4+ cells (and, to a 
lesser extent, CD8+ cells) expressed P2Y6 receptors after exposure 
in vivo to allergen (Figure 5). Moreover, the absence of P2Y6 
receptor expression on B220+ B cells is consistent with the lack of 
immunostaining of germinal centers (Figure 4C). Because the 
numbers of CD11c+ APCs in the PLNs were very small, we were 
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unable to determine whether they expressed P2Y6 receptors, 
although APCs enriched from the lung did express P2Y6 receptors 
that were upregulated with Df treatment (Figures 8B and 8C). 
To evaluate the functions of P2Y6 receptors on the secondary 
lymphoid organs, we next sought to determine the effects of P2Y6 
receptor deletion on the recall response to antigen. The PLNs from 
the Df-treated p2ry6 (flox/flox);cre/+ mice contained more total 
cells (Figure 6A) than did the PLNs from the +/+ controls. 
Although the total percentages of T cells in the PLNs did not differ 
between the strains (data not shown), the restimulated PLN cells 
from the Df-treated p2ry6 (flox/flox);cre/+ mice generated 
significantly higher amounts of Th1 and Th2 cytokines than did 
samples from the +/+ mice (Figure 6B), paralleled by higher 
numbers of cytokine producing T cells (Figure 6C). Combined with 
the stronger induction of both T-bet and GATA-3 in the PLNs from 
p2ry6 (flox/flox);cre/+ mice than in the PLNs from +/+ controls, the 
data argue that the effect of P2Y6 receptors on the control of 
antigen recall responses is not restricted to one lineage of effector T 
cell. Moreover, the robust generation of IL-10 (Figure 6B) by the 
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samples from p2ry6 (flox/flox);cre/+ mice, and the induction of 
comparable levels of the mRNA encoding Foxp3 in PLN cells from 
+/+ and p2ry6 (flox/flox);cre/+ mice following exposure to Df 
suggest that the absence of P2Y6 does not impair induction of 
regulatory T cells as a mechanism to account for the increased Df-
induced inflammatory response. Our data argue that P2Y6 
receptors, induced by antigen stimulation, play a homeostatic role 
in the control of memory T cell activation during recall responses. 
The modest increment in proliferation observed in the polyclonally 
stimulated CD4+ PLN T cells from p2ry6 (flox/flox);cre/+ mice 
compared with +/+ control cells is also consistent with a 
homeostatic role for P2Y6, although proof of such a role in control 
of antigen induced proliferation awaits the creation of transgenic 
mice with T cell receptors specific for Df antigens. 
In addition to intrinsic properties of the responder T cells, 
factors that regulate the phenotype of APCs can strongly influence 
the magnitude and nature of antigen-induced recall responses 
(Barrett and Austen, 2009; Barrett et al., 2009; Giannattasio et al., 
2010; Trompette et al., 2009). To test whether expression of P2Y6 
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receptors by APCs, by effector T cells, or by both cell types was 
relevant to the outcome of the Df-induced recall response, we 
developed a crossover assay in which purified P2Y6 receptor-
deficient or -sufficient splenic CD4+ T cells were co-cultured with 
either P2Y6 receptor-deficient or -sufficient lung interstitial 
macrophages as a source of P2Y6-expressing APCs (Figures 4B and 
8C) (Hume, 2008). The induction of inflammation by Df causes 
APCs to mature and become more effective in processing and 
presenting antigen, likely explaining the ability of the CD4+ cells to 
produce higher level of cytokines when co-cultured with APC that 
were derived from Df-treated mice. The absence of P2Y6 receptors 
from the lung macrophages did not affect the expression of 
activated APC markers CD11c and MHC-II (Figure 8B). Moreover, 
the macrophage genotype had no influence on the levels of 
cytokines generated by responder T cells, whereas the CD4+ cells 
from the Df-treated p2ry6 (flox/flox);cre/+ mice generated more IL-
5, IL-13, and IFN-γ than did the CD4+ T cells from the +/+ controls 
(Figure 9). Thus, at least at the effector phase of the Df-induced 
immune response, the upregulation of P2Y6 on Df-treated CD4+ 
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cells is both necessary and sufficient to dampen the production of 
cytokines in response to stimulation with the allergen in a recall 
response, suggesting that P2Y6 receptors intrinsically control T cell 
activation in response to antigen. 
Our study demonstrates the first homeostatic role of P2Y6 
receptors in the intrinsic control of effector T cell responses to 
clinically relevant allergens. The findings indicate a P2Y6 receptor-
dependent suppressive function for the uracil nucleotides that are 
generated in the inflammatory milieu during exposure to dust mite 
allergens. Two recent studies reported that uridine, the precursor of 
UDP and UTP, has a protective function in two models of acute 
lung inflammation by acting on epithelial cells (Evaldsson et al., 
2007; Müller et al., 2010). Thus, uracil and its derivatives may 
suppress allergic pulmonary inflammation by several mechanisms, 
contrasting with the proinflammatory effects of adenine nucleotides 
in a similar context. Given the multitude of P2Y receptors that are 
expressed by cells of the immune system, it is critical to understand 
both the pro- and anti-inflammatory effects of any P2Y receptor 
 45
that is envisioned as a potential target for drug development in the 
treatment of inflammatory diseases. 
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Figure  Legends 
 
Figure 1. Generation of +/+ and p2ry6 (flox/flox);cre/+ mice 
(A) The conditional gene-targeting vector was obtained from an 
~12.7 kb B6 bacterial artificial chromosome subclone and 
contained a long homology arm (LA; 9.6 kb), p2ry6 exons 2 and 3, 
the latter flanked at the 5′ side by a single loxP site and at the 3′ side 
by a PKG-neo cassette with loxP and FRT sites, and a short 
homology arm (SA; 2.1 kb). The target region was ~1.8 kb and 
included exon 3. The annealing sites of the primers used to confirm 
the structure of the vector are indicated as P6, N7, N1, and T7. 
(B) Schematic representation of the breeding protocol used to 
generate +/+ and p2ry6 (flox/flox);cre/+ mice. P2ry6 (flox/flox) 
mice on a C57BL/6 x 129 mixed background (dashed line) or on a 
C57BL/6 background (solid line) were initially mated with cre/cre 
mice to generate +/+ and p2ry6 (flox/flox);cre/+ strains. 
(C) PCR amplification products of the wild-type (p2ry6WT) and 
floxed (p2ry6flox) p2ry6 gene and of the Cre recombinase in 
C57BL/6 wild-type (lanes 3-5), p2ry6 (flox/flox) (lanes 7-9) and 
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p2ry6 (flox/flox);cre/+ (lanes 11-13) mice, resolved on a 2% 
agarose gel. 
 
Figure 2. Pulmonary inflammation in NaCl- and Df-treated +/+ 
and p2ry6 (flox/flox);cre/+ mice 
(A) Total and differential cell counts from BAL fluid of NaCl-and 
Df-treated +/+ (open bars; n = 9 and 23, respectively) and p2ry6 
(flox/flox);cre/+ (filled bars; n = 9 and 18) mice at the F1 stage of 
breeding. 
(B) Total and differential cell counts from BAL fluid of NaCl-and 
Df-treated C57BL/6 +/+ (open bars; n = 5 and 19, respectively) and 
p2ry6 (flox/flox);cre/+ (filled bars; n = 5 and 20) mice at the N10 
stage. 
(C) Tissue sections of lung showing BVBs from NaCl- and Df-
treated +/+ and p2ry6 (flox/flox);cre/+ mice were stained with 
hematoxylin-azue-2 eosin for assessing inflammatory cell infiltrates 
(H&E x20) and demonstrating tissue eosinophils (H&E x63, arrow 
heads) or by PAS reaction for depicting mucus-secreting cells (PAS 
x20, arrows). Scale bars, 100 (x20) or 25 (x63) μm. 
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(D) Expression of mRNA transcripts for cytokines and mucus-
associated proteins in the lung tissue of NaCl- and Df-treated +/+ (n 
= 6 and 18, respectively) and p2ry6 (flox/flox);cre/+ (n = 6 and 15) 
mice, measured by qPCR. Data are expressed as ratio of the 
indicated mRNA expression relative to GAPDH mRNA. 
Values are mean ± SEM from four (A) and three (B) independent 
experiments. Pictures in (C) are from one representative mouse per 
group from one of three independent experiments with similar 
results. Original magnifications, x20 and x63. 
 
Figure 3. Df-induced pulmonary inflammation and PLN 
cellularity and cytokine release in NaCl- and Df-treated 
C57BL/6 WT and cre/+ mice 
(A) Total and differential cell counts from BAL fluid of NaCl-and 
Df-treated C57BL/6 WT (open bars; n = 8 and 17, respectively) and 
cre/+ (filled bars; n = 7 and 18) mice. 
(B) Number of cells obtained from PLNs of NaCl- and Df-treated 
C57BL/6 WT and cre/+ mice. 
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(C) Cytokine release from restimulated PLN cells of Df-treated 
C57BL/6 WT and cre/+ mice. 
Values are mean ± SEM from two independent experiments. 
 
Figure 4. Expression of P2Y6 receptors in the lungs, PLNs and 
spleen 
(A) qPCR analysis of P2Y6 receptor mRNA levels in the lungs of 
NaCl- and Df-treated +/+ (open bars; n = 6 and 18, respectively) 
and p2ry6 (flox/flox);cre/+ (filled bars; n = 6 and 15) mice. 
(B) Immunohistochemical analysis of P2Y6 receptors in the lungs 
from +/+ and p2ry6 (flox/flox);cre/+ mice exposed to NaCl and Df 
intranasally. P2Y6 receptor protein, indicated by the brown staining, 
was detected on cells with the morphology consistent with 
macrophages (upper left panel, insert) in the lung of +/+ naïve mice 
and on both macrophages (lower left panel, left insert) and 
lymphocytes (right insert) in the bronchus-associated lymphoid 
tissues of +/+ mice. No staining was detected in the lung of NaCl- 
and Df-treated p2ry6 (flox/flox);cre/+ mice (right panels). Scale bar, 
25 μm. 
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(C) Immunohistochemistry of P2Y6 receptors in PLNs and spleen 
of NaCl- and Df-treated +/+ and p2ry6 (flox/flox);cre/+ mice. P2Y6 
receptors were detected on cells located in paracortical T cell-
dependent areas of the organs (arrows), as shown in the inserts at 
higher magnification. Scale bars, 100 μm. 
Values in (A) are mean ± SEM from three independent 
experiments. Pictures in (B) and (C) are from one representative 
mouse per group from one of two independent experiments with 
similar results. Original magnification, x63 (B), x20 and x63 (C). 
 
Figure 5. Cytofluorographic detection of P2Y6 receptors on 
PLN cell subsets 
(A) Dot plots showing the FSC/SSC gated cells and the analysis of 
the expression of CD4, CD11c, CD8, and B220 on PLN cells from 
Df-treated +/+ mice. Percentages of positive and negative cells are 
displayed. 
(B) Histograms showing the expression of P2Y6 receptors (blue 
lines) vs. isotype control (red lines) on CD4 +, CD8+, and B220+-
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gated PLN cells in NaCl- and Df-treated +/+ and p2ry6 
(flox/flox);cre/+ mice. 
Panels are from one experiment representative of two with similar 
results. 
 
Figure 6. PLN cellularity and T cell responses 
(A) Number of cells obtained from PLNs of NaCl- and Df-treated 
+/+ (open bars; n = 5 and 17, respectively) and p2ry6 
(flox/flox);cre/+ (filled bars; n = 5 and 17) mice. 
(B) ELISA measurement of cytokine release from restimulated PLN 
cells of Df-treated +/+ (n = 16) and p2ry6 (flox/flox);cre/+ (n = 17) 
mice. 
(C) Number of cytokine-producing cells in PLN cells of Df-treated 
+/+ (n = 15) and p2ry6 (flox/flox);cre/+ (n = 13) mice. 
(D) Proliferation (based on CFDA-SE dilution) of CD4+-gated 
PLN cells from NaCl- and Df-treated +/+ and p2ry6 
(flox/flox);cre/+ mice cultured with plate-bound anti-CD3 and 
soluble anti-CD28 antibodies. The FSC/SSC and CD4/SSC dot 
plots shown in the figure represent data from Df-treated +/+ mice. 
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Values in (A), (B), and (C) are mean ± SEM from three 
independent experiments. Panels in (D) are from one representative 
mouse per group from one of two independent experiments with 
similar results. The mean data are presented in the text. 
 
Figure 7. Immunoglobulin levels in serum of NaCl- and Df-
treated +/+ and p2ry6 (flox/flox);cre/+ mice 
(A) Total IgE and (B) Df-specific IgG1 in serum of NaCl- and Df-
treated +/+ (open bars; n = 10 and 20, respectively) and p2ry6 
(flox/flox);cre/+ (filled bars; n = 11 and 17) mice were measured by 
ELISA. Values are mean ± SEM from four independent 
experiments. 
 
Figure 8. Characterization of interstitial macrophages enriched 
from lungs of Df-treated +/+ and p2ry6 (flox/flox);cre/+ mice 
(A) Diff-quick staining of a preparation of lung interstitial 
macrophages from Df +/+ treated mice. 
(B) Cytofluorographic characterization of interstitial macrophages 
obtained from the lung of Df-treated +/+ and p2ry6 (flox/flox);cre/+ 
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mice. The dot plots show the gated populations based on FSC and 
SSC values and the expression of CD68 and CD11c on the gated 
cells. The histograms show the expression of MHC-II (blue lines) 
vs. the isotype control (red lines) on the CD68+ cells. 
(C) Confocal microscopy analysis of P2Y6 receptor expression on 
lung interstitial macrophages obtained from NaCl- and Df-treated 
+/+ and p2ry6 (flox/flox);cre/+ mice. 
Pictures in (A) and (C) are from one mouse per group from one of 
four independent experiments. Panels in (B) are from one 
experiment representative of two with similar results. 
 
Figure 9. Cytokine release from restimulated cocultures of 
CD4+ T cells and lung macrophages 
Lung macrophages from NaCl- and Df-treated +/+ and p2ry6 
(flox/flox);cre/+ mice were co-cultured with CD4+ T cells from +/+ 
(open bars) and p2ry6 (flox/flox);cre/+ (filled bars) mice treated 
with NaCl (left panels) or Df (right panels). Values are from one 
experiment representative of three with similar results. 
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